Guidance on applications for drug clinical trials under the interim order: Overview - Guidance on applications for drug clinical trials under the interim order: Post-authorization requirements
There are no views created for this resource yet.
Additional Information
Created | May 28, 2021 |
---|---|
Format | HTML |